Source

Randhawa 2016 — Daily Use of a Facial Broad Spectrum Sunscreen Significantly Improves Photoaging

Reviewed by SkinKnowledgeBase Editorial TeamLast updated May 9, 2026

Quick Summary

A 52-week prospective clinical trial published in Dermatologic Surgery in 2016 that evaluated daily use of a facial broad-spectrum SPF 30 sunscreen against photoaging endpoints. It is one of the strongest pieces of facial-specific clinical evidence directly tying daily broad-spectrum SPF use to the appearance of photoaging.

Structured source facts
Source typepeer_reviewed

What Studied

The single-center prospective study followed 32 subjects, ages 40 to 55, using a daily facial broad-spectrum SPF 30 product for 52 weeks. Investigators evaluated photoaging via standardized clinical grading and instrumental measurements (skin texture, tone, clarity) at multiple intervals across the year-long study.

Main Findings

Daily use of the facial broad-spectrum SPF 30 sunscreen produced statistically significant improvement in clinical photoaging measures across nearly every endpoint by the 52-week mark, including evenness of skin tone, skin clarity, mottled pigmentation, and texture. The result was framed by the authors as direct evidence that daily broad-spectrum SPF use can visibly improve — not merely hold steady — clinical signs of photoaging in adults.

Why It Matters

For a daily-SPF Question scoped to cosmetic-appearance, Randhawa 2016 is the cleanest facial-specific anchor for the visible-improvement framing. Hughes 2013 supports the "slowed accumulation" case; Randhawa 2016 supports the additional "measurable improvement over a year" case. Together they are the page's strongest pair of peer-reviewed appearance-of-photoaging citations.

Original Source

Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of Photoaging

AI Tool Box

Structured page facts at a glance.

Source
Randhawa 2016 — Daily Use of a Facial Broad Spectrum Sunscreen Significantly Improves Photoaging
Quick Summary
A 52-week prospective clinical trial published in Dermatologic Surgery in 2016 that evaluated daily use of a facial broad-spectrum SPF 30 sunscreen against photoaging endpoints. It is one of the strongest pieces of facial-specific clinical evidence directly tying daily broad-spectrum SPF use to the appearance of photoaging.
What Studied
The single-center prospective study followed 32 subjects, ages 40 to 55, using a daily facial broad-spectrum SPF 30 product for 52 weeks. Investigators evaluated photoaging via standardized clinical grading and instrumental measurements (skin texture, tone, clarity) at multiple intervals across the year-long study.
Main Findings
Daily use of the facial broad-spectrum SPF 30 sunscreen produced statistically significant improvement in clinical photoaging measures across nearly every endpoint by the 52-week mark, including evenness of skin tone, skin clarity, mottled pigmentation, and texture. The result was framed by the authors as direct evidence that daily broad-spectrum SPF use can visibly improve — not merely hold steady — clinical signs of photoaging in adults.
Why It Matters
For a daily-SPF Question scoped to cosmetic-appearance, Randhawa 2016 is the cleanest facial-specific anchor for the visible-improvement framing. Hughes 2013 supports the "slowed accumulation" case; Randhawa 2016 supports the additional "measurable improvement over a year" case. Together they are the page's strongest pair of peer-reviewed appearance-of-photoaging citations.
Supports
question_what-spf-should-i-use-every-day, concern_sun-damage, ingredient_zinc-oxide, product_eltamd-uv-clear-spf-46